Optic pathway gliomas: neoplasms, not hamartomas.

Area of Science:

• Neuro-ophthalmology
• Pediatric Oncology
• Pathology

Background:

• Optic pathway gliomas (OPGs) are a significant cause of vision loss in children.
• The classification of OPGs as neoplasms or hamartomas impacts management strategies.

Purpose of the Study:

• To present evidence supporting the classification of optic pathway gliomas as slow-growing neoplasms.
• To differentiate OPGs from hamartomas based on growth patterns and histopathology.

Main Methods:

• A comprehensive review of existing literature on optic pathway gliomas.
• Analysis of studies conducted at a pediatric tertiary referral center.

Main Results:

• Histopathological and growth patterns of OPGs align with neoplastic characteristics.
• Spontaneous regression, previously associated with hamartomas, is also observed in neoplasms, including OPGs.
• Chemotherapy effective for low-grade gliomas has shown promise in halting or improving vision in OPGs.

Conclusions:

• Optic pathway gliomas are definitively classified as neoplasms, not hamartomas.
• Close patient monitoring and the use of chemotherapy for clinical progression are recommended.
• Future research is expected to yield more targeted therapeutic options for OPGs.